摘要
近年来,随着各种类型抗心血管损伤新药在临床上的广泛应用,国际上将部分新型治疗方法列入心脏衰竭治疗标准指南。主要的新型治疗方法包括:(1)松弛肽治疗急性心脏衰竭(RELAX-AHF);(2)超滤抢救急性心脏衰竭(CARRESS-HF);(3)自动植入式除颤治疗急性心脏衰竭(MADIT-RIT);(4)双室起搏治疗急性心脏衰竭(BLOCK-HF)。这些治疗方法较常用的方法虽易导致心率加快,但亦显示2个明显优势,即显著降低第一次不适当治疗的累积概率;明显降低随访期间患者的病死率。为使广大科研工作者和医护人员对心脏衰竭治疗有更进一步的了解,本文通过对国内外急性心脏衰竭的大量病例治疗过程和结果进行分析,对急性心脏衰竭的药物治疗和手术治疗进行了介绍,并且对心脏衰竭发生过程中伴有并发症的治疗方法进行了阐述。
Recently,with the wide application of various types of anti-cardiovascular damage drugs in cardiovascular clinic, some new therapeutic methods have been classified as treatment for heart failure in the International Guidelines.These methods include:(1) relaxin treatment of acute heart failure(RELAX-AHF);(2) ultrafiltration treatment of acute heart failure(CARRESS-HF);(3) the automatic implantable defibrillator therapy in the treatment of acute heart failure(MADIT-RIT); and(4) dual chamber pacing for the treatment of acute heart failure(BLOCK-HF).Although these new treatment methods may result in increased heart rate,there are two obvious advantages in using these new methods: significantly reduced the cumulative probability of the first inappropriate treatment; and significantly reduced mortality during follow-up period.This review has introduced the current status and progress in the treatment of acute heart failure both in internal medicine and invasive surgery,and has reviewed problem-solving methods dealing with the complications occurred during treatment of acute heart failure.
出处
《创伤与急危重病医学》
2013年第1期9-12,共4页
Trauma and Critical Care Medicine
基金
全军"十二五"科技攻关项目(CSY12J002)
